Uguz, Faruk2024-02-232024-02-2320202475-05732475-0581https://doi.org/10.5455/PCP.20200502080433https://hdl.handle.net/20.500.12452/16899Antipsychotic medications are frequently used in clinical practice. Clozapine is considered to be the most effective antipsychotic treatment in patients with treatment-resistant schizophrenia. Although clozapine has been available in the market for a long time, safety data on its usage during the lactation period are very limited. The current report presents the short-term clinical outcome of infants exposed via breastfeeding to maternal clozapine at 75-mg/day.eninfo:eu-repo/semantics/openAccessClozapineLactationBreastfeedingAntipsychoticsArticle3021931952-s2.0-85129808092Q3WOS:000604930500015Q410.5455/PCP.20200502080433